Association of biomarkers (BMs) with efficacy of adjuvant nivolumab (NIVO) vs placebo (PBO) in patients with resected stage IIB/C melanoma (CA209-76K).

Georgina V. Long, Michele Del Vecchio, John M. Kirkwood et al.|Journal of Clinical Oncology|2023

Cited by 13